9YANG Y X, HENNESSY S, LEWIS J D. Type 2 diabetes mellitus and the risk of colorectal cancer [ J ]. Clin Gastroenterol Hepatol, 2005, 3 (6): 587-594.
10MEYERHARDT J A, CATALANO P J, HALLER D G, et al. Impact of diabetes mellitus on outcomes in patients with colon cancer[J]. J Clin Oncol, 2003, 21 (3) : 433-440.
5Li J, Ma Q. Hyperglycemia promotes the perineural invasion in pancreatic Cancer [J]. Med Hypotheses, 2008, 71 (3): 386-389.
6Dehal A N, Newton C C, Jaeobs E J, et al. Impact of diabetes mellitus and insulin use on survival after coloreetal cancer diagno- sis: the Cancer Prevention Study-II Nutrition Cohort [J]. J ClinOncol, 2012, 30 (1): 53-59.
7Ding J, Tang J, Chen X, et al. Expression characteristics of proteins of the insulin-like growth factor axis in non small cell lung cancer patients with preexisting type 2 diabetes mellitus [J]. Asian Pac J Cancer Prev, 2013, 14 (10):5675 5680.
8Kobayashi T. Karnata K. Short-term insulin treatment and aor- tic expressions of IGF-1 receptor and VEGF mRNA in diabetic rats[J]. Am J Physiol Heart Circ Physiol, 2002, 283 (5): 1761-1768.
9K0ng Y, Bai P S, Nan K J, et al. Pleiotrophin is a potential eolorectal cancer prognostic factor that promotes VEGF expre8 sion and induces angiogenesis in eolorectal cancer [J]. Int J ColorectalDi~, 2012, 27 (3); 287 298.
10McAlpine RR,Morris AD,Emslie-Smith A,et al.The annual incidence of diabetic complications in a population of patients with Type 1 and Type 2 diabetes[J].Diabet Med,2005,22(3):348-352.
